glp 1 gip gcg receptor agonist Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Potency: Achieving Comparable Glycemic and Weight Reduction Effects GLP-1, GIP and glucagon receptor
Description
Sharma A, Ambrosy AP, DeVore AD, Margulies KB, McNulty SE, Mentz RJ, Hernandez AF, Michael Felker G, Cooper LB, Lala A
The fatigue profile tends to be milder with liraglutide, and some patients prefer the daily dosing because it provides more flexible dose adjustment opportunities
[PubMed ID: 23613622]
Welcome to Hospitalogy, a newsletter breaking down healthcare finance, M&A, and strategy twice weekly
At the moment we're not facing the same stock issues that we've seen a couple years ago
